Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on mesenchymal stem cells for inflammatory bowel diseases across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hanan Jafar | Conditions: Inflammatory Bowel Diseases | Phase 1, Phase 2 | Status: UNKNOWN